Thetha Nami Ngithethe Nawe ("Let's Talk"): Step Wedge cRCT of Peer Led Community PrEP and SRH for Youth in South Africa
Launched by AFRICA HEALTH RESEARCH INSTITUTE · Jun 1, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The "Let's Talk" trial is studying a new way to help young people in South Africa, aged 15 to 30, reduce their risk of getting HIV and other sexually transmitted infections (STIs). The goal is to see if providing support from trained peers and easy access to sexual and reproductive health services—like HIV testing, counseling, and safe spaces—can encourage more young people to seek out these important health services. By comparing this peer-led approach to the usual health services, researchers hope to find out if it can lower the number of young people with HIV in the community.
To participate in this study, individuals need to be between 15 and 30 years old and living in the uMkhanyakude district. If participants are 18 or older, they can give their own consent, while those aged 15 to 17 will need permission from a parent or guardian. During the study, participants can expect to engage in supportive activities, receive health assessments, and access resources like condoms and HIV tests. The research will last for three years, and the information collected will help improve HIV prevention strategies for young people in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Resident in the cluster
- • Any gender
- • Aged 15-30
- • If aged 18-30 and able and willing to consent to participate
- • If aged 15-17, able and willing to assent and whose guardian or parent are able and willing to consent to their participation.
- Exclusion Criteria:
- • Unable or unwilling to provide consent
- • Aged 14 or less
- • aged 31 or more
About Africa Health Research Institute
The Africa Health Research Institute (AHRI) is a leading research organization dedicated to addressing the health challenges faced by populations in Africa through innovative and impactful scientific inquiry. With a focus on infectious diseases, particularly HIV and tuberculosis, AHRI conducts cutting-edge clinical trials and epidemiological studies to generate robust data that inform public health strategies and interventions. The institute fosters collaborative partnerships with local and international stakeholders, emphasizing capacity building and knowledge transfer to enhance the research landscape in Africa. Committed to improving health outcomes, AHRI plays a pivotal role in advancing health research that is culturally relevant and scientifically rigorous.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Somkele, Kwazulu Natal, South Africa
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials